EPZM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EPZM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Expenses only applies to insurance companies.
Jeffery Kutok | officer: Chief Scientific Officer | 784 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Jerald Korn | officer: Chief Operating Officer | 128 GORDON RD, NEWTON MA 02468 |
Joseph Beaulieu | officer: Corporate Controller | C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 |
Shefali Agarwal | officer: Chief Medical Officer | C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139 |
Royalty Pharma Investments 2019 Icav | director, 10 percent owner | C/O RP MANAGEMENT, LLC 100 E. 59TH ST., 33RD FLOOR NEW YORK NY 10022 |
Pablo G. Legorreta | director | 110 E 59TH STREET, SUITE 3300, NEW YORK NY 10022 |
Carol Stuckley | director | C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Roy A Beveridge, | director | 500 W MAIN ST, LOUISVILLE KY 40202 |
David M Mott | director | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
Robert B Bazemore | director, officer: President & CEO | 33 HAYDEN AVE, LEXINGTON MA 02421 |
Matthew Ros | officer: Chief Operating Officer | C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139 |
Paolo Tombesi | officer: Chief Financial Officer | 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807 |
Victoria Vakiener | officer: Chief Commercial Officer | C/O EPIZYME, INC., 400 TECHNOLOGY SQUARE, CAMBRIDGE MA 02139 |
Carl Goldfischer | director | 161 WEST 61ST STREET, NEW YORK NY 10022 |
Rp Management, Llc | director | 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.